Fibromyalgia syndrome module at OMERACT 9: domain construct

…, SA Martin, J Morea, L Simon, CV Strand… - The Journal of …, 2009 - jrheum.org
The objective of the module was to (1) establish a core domain set for fibromyalgia (FM)
assessment in clinical trials and practice, (2) review outcome measure performance …

Minimal disease activity for rheumatoid arthritis: a preliminary definition.

…, B Shea, PM Brooks, LS Simon, CV Strand… - The Journal of …, 2005 - jrheum.org
Agreement on response criteria in rheumatoid arthritis (RA) has allowed better standardization
and interpretation of clinical trial reports. With recent advances in therapy, the proportion …

Fibromyalgia syndrome.

…, LS Simon, CV Strand, C Bramson… - The Journal of …, 2005 - jrheum.org
The objectives of the first OMERACT Fibromyalgia Syndrome (FM) Workshop were to identify
and prioritize symptom domains that should be consistently evaluated in FM clinical trials, …

Measuring worker productivity: frameworks and measures

…, A Boonen, RH Osborne, AH Anis, CV Strand… - The Journal of …, 2009 - jrheum.org
Worker productivity is a combination of time off work (absenteeism) due to an illness and time
at work but with reduced levels of productivity while at work (also known as presenteeism). …

Developing a standardized definition for disease “flare” in rheumatoid arthritis (OMERACT 9 Special Interest Group)

…, MU Rahman, JP Witter, DE Furst, CV Strand… - The Journal of …, 2009 - jrheum.org
Objective. Traditional outcome measures in randomized controlled trials (RCT) include well-established
response criteria as well as ACR EULAR responses using Disease Activity …

Leflunomide: a manageable safety profile.

…, P Emery, JR Kalden, M Dougados, CV Strand… - The Journal of …, 2004 - jrheum.org
The safety profile of leflunomide in the treatment of rheumatoid arthritis has been well
documented in clinical trials, postmarketing surveillance, and epidemiological studies. Both …

Content and criterion validity of the preliminary core dataset for clinical trials in fibromyalgia syndrome

…, JM Glass, LS Simon, SA Martin, CV Strand… - The Journal of …, 2009 - jrheum.org
Objective. Increasing research interest and emerging new therapies for treatment of fibromyalgia
(FM) have led to a need to develop a consensus on a core set of outcome measures …

Outcome measures in psoriatic arthritis.

…, P Nash, CT Ritchlin, CV Strand… - The Journal of …, 2005 - jrheum.org
Recent advances in biologic therapies have provided hope for patients with psoriatic arthritis
(PsA). However, studies have been hampered by the lack of acceptable and validated …

The efficacy of leflunomide monotherapy in rheumatoid arthritis: towards the goals of disease modifying antirheumatic drug therapy.

…, PLCM Van Riel, M Dougados, CV Strand… - The Journal of …, 2004 - jrheum.org
This expert review of results from the leflunomide phase II and III clinical trials database
demonstrates that leflunomide meets all 3 goals desired of disease modifying antirheumatic drug …

Measures of response in clinical trials of systemic sclerosis: the Combined Response Index for Systemic Sclerosis (CRISS) and Outcome Measures in Pulmonary …

…, L Rubin, JR Seibold, V Steen, CV Strand… - The Journal of …, 2009 - jrheum.org
… (c) We will revise and define a final core set based on results … from data gathered as part of
1(c), above, from diffuse SSc patients … (c) We will use ratings of key opinion leaders as a gold …